Patents Assigned to Cerenis Therapeutics Holding S.A.
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 11376309
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: July 5, 2022
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20190298800
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: April 29, 2019
    Publication date: October 3, 2019
    Applicant: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 10328119
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: June 25, 2019
    Assignee: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 10322163
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: June 18, 2019
    Assignee: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • CHARGED LIPOPROTEIN COMPLEXES AND THEIR USES
    Publication number: 20170182121
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Application
    Filed: January 4, 2017
    Publication date: June 29, 2017
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis DASSEUX
  • Charged lipoprotein complexes and their uses
    Patent number: 9567388
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: February 14, 2017
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis Dasseux
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20160095901
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: October 15, 2015
    Publication date: April 7, 2016
    Applicant: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 9187551
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: November 17, 2015
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20140213501
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: December 11, 2013
    Publication date: July 31, 2014
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • CHARGED LIPOPROTEIN COMPLEXES AND THEIR USES
    Publication number: 20140206600
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Application
    Filed: November 20, 2013
    Publication date: July 24, 2014
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis DASSEUX
  • CHARGED LIPOPROTEIN COMPLEXES AND THEIR USES
    Publication number: 20120245328
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Application
    Filed: May 3, 2012
    Publication date: September 27, 2012
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis Dasseux
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20120232005
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: February 6, 2012
    Publication date: September 13, 2012
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Daniela Carmen Oniciu, Rose Ackermann
  • Charged lipoprotein complexes and their uses
    Patent number: 8206750
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: June 26, 2012
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis Dasseux